마그네타이트 나노입자 시장 보고서 : 유형별, 물리적 형태별, 용도별, 지역별(2025-2033년)

The global magnetite nanoparticles market size reached USD 89.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 204.8 Million by 2033, exhibiting a growth rate (CAGR) of 9.11% during 2025-2033.

Magnetite nanoparticles (NPs) are structures composed of different metallic elements, such as iron, cobalt, nickel, and platinum, or metal alloys, which exhibit superparamagnetic properties at ambient temperatures. Their compact size and non-toxic properties make them viable for applications in catalysis, biosensors, ferrofluids, magnetic separations, and magnetic resonance imaging (MRI) contrast agents. Due to their high coercivity, low curie temperature, and excellent magnetic susceptibility, magnetite NPs have now become an important element in developing novel biomedical applications. They are consequently used in nanotoxicology and magnetic nanotechnology research and development (R&D) across the globe.

Magnetite Nanoparticles Market Trends:

Magnetite NPs find extensive applications in cancer therapy, drug nanocarriers (NCs), targeted delivery systems, and diagnosis involving two guided NPs as nanoprobes and contrast agents. This, in confluence with the increasing prevalence of chronic diseases and the rising need for improved diagnostic modalities and personalized treatments, represents one of the key factors bolstering the market growth. Moreover, magnetic NPs are gaining traction in magnetic bio-separation and detection of biological entities, such as cells, proteins, nucleic acids, enzymes, bacteria, and viruses. Besides this, as the magnetic properties of magnetite NPS can efficiently remove contaminants from wastewater, they are considered suitable for wastewater treatment processes, including flocculation, demulsification, adsorption, filtration, and photocatalytic activities. In addition, rapidly diminishing freshwater resources and the growing wastewater complexities are driving the demand for magnetic NPs. Apart from this, researchers are focusing on obtaining functionalized magnetite NPs via green chemistry to reduce environmental pollution. Such developments are anticipated to aid the usage of magnetite NPs in various industrial applications and medical practices to improve the quality of life of the patients.

Key Market Segmentation:

Breakup by Type:

• Iron Based
• Cobalt Based

Breakup by Physical Form:

• Nanopowder
• Solution
• Dispersion

Breakup by Application:

• Bio-medical
• Electronics
• Wastewater Treatment
• Energy
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being American Elements, Cytodiagnostics Inc., Merck KGaA, Nano Research Elements Inc., nanoComposix (Fortis Life Sciences), Nanografi Nano Technology, Nanoshel LLC, Reade International Corp., SkySpring Nanomaterials Inc., Strem Chemicals Inc. and US Research Nanomaterials Inc.

Key Questions Answered in This Report

• 1.What was the size of the global magnetite nanoparticles market in 2024?
• 2.What is the expected growth rate of the global magnetite nanoparticles market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global magnetite nanoparticles market?
• 4.What are the key factors driving the global magnetite nanoparticles market?
• 5.What is the breakup of the global magnetite nanoparticles market based on the type?
• 6.What is the breakup of the global magnetite nanoparticles market based on the physical form?
• 7.What is the breakup of the global magnetite nanoparticles market based on the application?
• 8.What are the key regions in the global magnetite nanoparticles market?
• 9.Who are the key players/companies in the global magnetite nanoparticles market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Magnetite Nanoparticles Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Iron Based
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Cobalt Based
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Physical Form

• 7.1 Nanopowder
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Solution
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Dispersion
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Bio-medical
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Electronics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Wastewater Treatment
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Energy
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 American Elements
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Cytodiagnostics Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Merck KGaA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Nano Research Elements Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 nanoComposix (Fortis Life Sciences)
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Nanografi Nano Technology
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Nanoshel LLC
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Reade International Corp.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 SkySpring Nanomaterials Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Strem Chemicals Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 US Research Nanomaterials Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio